MarketCap
Facebook
X
TelegramQuarterly report 2024-Q3
added 12-16-2024
Enzo Biochem ROE Ratio 2011-2025 | ENZ
Annual ROE Ratio Enzo Biochem
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -46.47 | 25.86 | -33.53 | 11.48 | -48.85 | 2.89 | -12.72 | -2.82 | 50.57 | -5.36 | -27.0 | -53.43 | -79.98 | -14.61 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 50.57 | -79.98 | -16.71 |
Quarterly ROE Ratio Enzo Biochem
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -20.16 | -17.61 | -97.84 | -173.7 | -203.86 | -138.35 | -146.16 | -73.73 | -35.52 | -7.55 | -3.76 | 7.05 | -7.52 | -3.54 | -12.97 | -15.47 | -17.08 | -27.35 | -28.6 | -4.63 | 6.8 | 8.66 | 8.44 | -23.93 | -24.1 | -16.92 | -9.72 | -2.53 | 11.22 | 10.27 | 50.51 | 49.59 | 25.3 | 36.36 | 15.82 | 27.88 | 28.53 | 8.82 | -19.57 | -40.07 | -43.08 | -41.17 | -41.68 | -39.76 | -31.03 | -30.68 | -76.87 | -76.23 | -76.26 | -73.56 | -22.82 | -14.98 | -5.38 | -4.53 | -5.07 |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 50.51 | -203.86 | -26.55 |
ROE Ratio of other stocks in the Diagnostics research industry
| Issuer | ROE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
-170.35 | - | -6.23 % | $ 30.6 M |  Germany |
|
Akumin
AKU
|
325.23 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Brainsway Ltd.
BWAY
|
-27.43 | $ 16.97 | - | $ 99.4 M |  Israel |
 |
Burning Rock Biotech Limited
BNR
|
-43.17 | $ 15.75 | -7.62 % | $ 169 M |  China |
 |
Accelerate Diagnostics
AXDX
|
65.62 | - | -61.36 % | $ 2.46 M |  USA |
 |
Biocept
BIOC
|
-362.16 | - | -13.05 % | $ 7.29 M | USA |
 |
BioNano Genomics
BNGO
|
-316.66 | $ 1.62 | -2.41 % | $ 2.06 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
-0.85 | - | - | $ 562 M |  Britain |
 |
Castle Biosciences
CSTL
|
4.0 | $ 38.63 | 1.74 % | $ 1.07 B | USA |
 |
Chembio Diagnostics
CEMI
|
-130.86 | - | 0.22 % | $ 16.8 M | USA |
 |
Danaher Corporation
DHR
|
7.87 | $ 226.33 | -2.6 % | $ 165 B | USA |
 |
DarioHealth Corp.
DRIO
|
-102.21 | $ 11.89 | -6.82 % | $ 337 M | Israel |
 |
DexCom
DXCM
|
26.18 | $ 66.96 | - | $ 25.8 B | USA |
 |
IQVIA Holdings
IQV
|
22.63 | $ 222.26 | - | $ 40.3 B | USA |
 |
Fulgent Genetics
FLGT
|
-3.77 | $ 27.14 | 0.3 % | $ 821 M | USA |
 |
Global Cord Blood Corporation
CO
|
10.27 | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
-38.13 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
-43.4 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-181.33 | - | 0.12 % | $ 80.1 M | China |
 |
DermTech
DMTK
|
-176.45 | - | -11.32 % | $ 2.94 M | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
13.32 | - | - | $ 10.7 B | USA |
 |
CareDx, Inc
CDNA
|
-72.81 | $ 20.56 | 3.84 % | $ 1.11 B | USA |
 |
Celcuity
CELC
|
-96.68 | $ 105.25 | - | $ 4.15 B | USA |
 |
Anixa Biosciences
ANIX
|
-62.78 | $ 3.58 | - | $ 114 K | USA |
 |
Exact Sciences Corporation
EXAS
|
-35.99 | $ 101.5 | - | $ 18.8 B | USA |
 |
Co-Diagnostics
CODX
|
-41.08 | $ 0.34 | - | $ 9.98 M | USA |
 |
Guardant Health
GH
|
312.48 | $ 102.07 | - | $ 12.5 B | USA |
 |
Aspira Women's Health
AWH
|
-403.65 | - | -6.19 % | $ 10.5 M | USA |
 |
Koninklijke Philips N.V.
PHG
|
9.97 | $ 26.62 | - | $ 20 B |  Niderland |
 |
Heska Corporation
HSKA
|
-4.71 | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
-400.51 | - | -20.0 % | $ 1.06 M | USA |
 |
Illumina
ILMN
|
-51.54 | $ 134.87 | - | $ 21.4 B | USA |
 |
Charles River Laboratories International
CRL
|
0.64 | $ 193.03 | - | $ 9.92 B | USA |
 |
Quotient Limited
QTNT
|
312.05 | - | -11.32 % | $ 1.1 M |  Schweiz |
 |
Quest Diagnostics Incorporated
DGX
|
12.85 | $ 182.56 | - | $ 20.3 B | USA |
|
Biodesix
BDSX
|
-205.65 | $ 7.85 | -2.12 % | $ 1.02 B | USA |
 |
Laboratory Corporation of America Holdings
LH
|
9.26 | $ 264.18 | -0.21 % | $ 22.2 B | USA |
 |
ICON Public Limited Company
ICLR
|
8.31 | $ 186.58 | - | $ 15.4 B |  Irlanda |
 |
IDEXX Laboratories
IDXX
|
55.65 | $ 704.2 | - | $ 58.1 B | USA |
 |
Mettler-Toledo International
MTD
|
-680.23 | $ 1 393.64 | - | $ 29.6 B | Schweiz |
 |
Lantheus Holdings
LNTH
|
28.72 | $ 66.62 | - | $ 4.61 B | USA |
 |
Agilent Technologies
A
|
22.45 | $ 139.68 | 0.01 % | $ 42.5 B | USA |
 |
Myriad Genetics
MYGN
|
-18.16 | $ 7.21 | - | $ 653 M | USA |
 |
NeoGenomics
NEO
|
-8.72 | $ 11.85 | - | $ 1.5 B | USA |
 |
Biomerica
BMRA
|
-121.14 | $ 2.58 | - | $ 5.93 M | USA |
 |
Neogen Corporation
NEOG
|
-52.72 | $ 6.86 | -2.56 % | $ 1.49 B | USA |
 |
Bioventus
BVS
|
-90.0 | $ 7.55 | 1.75 % | $ 473 M | USA |
 |
Check-Cap Ltd.
CHEK
|
1734.41 | - | - | $ 9.42 M | Israel |
 |
Motus GI Holdings
MOTS
|
-478.86 | - | -34.28 % | $ 263 K | Israel |